PAGLIARI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.549
AS - Asia 1.097
EU - Europa 594
SA - Sud America 211
AF - Africa 182
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 14
Totale 3.687
Nazione #
US - Stati Uniti d'America 1.440
SG - Singapore 388
IT - Italia 206
CN - Cina 188
BR - Brasile 135
HK - Hong Kong 99
VN - Vietnam 87
BD - Bangladesh 84
DE - Germania 51
FI - Finlandia 42
IN - India 38
PL - Polonia 35
FR - Francia 32
NL - Olanda 30
JP - Giappone 29
AR - Argentina 27
GB - Regno Unito 25
BJ - Benin 23
CA - Canada 23
ES - Italia 15
IQ - Iraq 15
MX - Messico 15
SE - Svezia 14
AT - Austria 13
RU - Federazione Russa 13
ID - Indonesia 12
PH - Filippine 12
TR - Turchia 12
ET - Etiopia 11
PK - Pakistan 11
UZ - Uzbekistan 11
EC - Ecuador 10
SA - Arabia Saudita 10
CO - Colombia 9
CZ - Repubblica Ceca 9
SK - Slovacchia (Repubblica Slovacca) 9
ZA - Sudafrica 9
CH - Svizzera 8
GT - Guatemala 8
AE - Emirati Arabi Uniti 7
AO - Angola 7
AZ - Azerbaigian 7
BE - Belgio 7
DZ - Algeria 7
KE - Kenya 7
KR - Corea 7
MA - Marocco 7
PA - Panama 7
VE - Venezuela 7
AL - Albania 6
CI - Costa d'Avorio 6
CW - ???statistics.table.value.countryCode.CW??? 6
DJ - Gibuti 6
GH - Ghana 6
HN - Honduras 6
HU - Ungheria 6
JM - Giamaica 6
ME - Montenegro 6
MY - Malesia 6
NE - Niger 6
TJ - Tagikistan 6
UY - Uruguay 6
YE - Yemen 6
ZM - Zambia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
GN - Guinea 5
GR - Grecia 5
IE - Irlanda 5
IL - Israele 5
IR - Iran 5
LV - Lettonia 5
MK - Macedonia 5
MN - Mongolia 5
PY - Paraguay 5
SN - Senegal 5
TH - Thailandia 5
UA - Ucraina 5
BF - Burkina Faso 4
BS - Bahamas 4
BY - Bielorussia 4
CG - Congo 4
CU - Cuba 4
CV - Capo Verde 4
EG - Egitto 4
GA - Gabon 4
HR - Croazia 4
JO - Giordania 4
MD - Moldavia 4
MU - Mauritius 4
NC - Nuova Caledonia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RE - Reunion 4
RS - Serbia 4
SO - Somalia 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
Totale 3.525
Città #
Singapore 252
Ashburn 247
San Jose 192
Hong Kong 90
Chandler 78
Fairfield 69
Santa Clara 62
Beijing 43
Ho Chi Minh City 41
Council Bluffs 40
Los Angeles 37
Cambridge 26
Tokyo 26
Padova 24
Cotonou 23
New York 23
Bytom 22
Munich 22
Woodbridge 22
Helsinki 20
Boardman 19
Hanoi 18
São Paulo 18
Lauterbourg 17
Des Moines 16
Wilmington 16
Chicago 15
Buffalo 14
Houston 14
Milan 14
Orem 14
Atlanta 13
San Diego 13
Turku 13
Hefei 11
Frankfurt am Main 10
Rome 10
Medford 9
Princeton 9
Tashkent 9
Addis Ababa 8
Amsterdam 8
Baghdad 8
Dallas 8
Legnaro 8
Naples 8
Warsaw 8
Cagliari 7
Denver 7
Lappeenranta 7
Luanda 7
Panama City 7
Quartu Sant'Elena 7
Redondo Beach 7
Seattle 7
Turin 7
Ann Arbor 6
Baku 6
Brooklyn 6
Chennai 6
Dhaka 6
Djibouti 6
Dushanbe 6
Guangzhou 6
Istanbul 6
Johannesburg 6
Lusaka 6
Mexico City 6
Montevideo 6
Niamey 6
Poplar 6
Rio de Janeiro 6
Toronto 6
Abidjan 5
Accra 5
Boston 5
Brasília 5
Bratislava 5
Conakry 5
Dakar 5
Lahore 5
Montreal 5
Phoenix 5
Podgorica 5
Riga 5
San Francisco 5
Sanaa 5
Seoul 5
Stockholm 5
Ulan Bator 5
Amman 4
Asunción 4
Athens 4
Boydton 4
Guatemala City 4
Jeddah 4
Libreville 4
London 4
Madrid 4
Managua 4
Totale 1.977
Nome #
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 395
Helicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transition 279
Helicobacter pylori affects the antigen presentation activity of macrophages modulating the expression of the immune receptor CD300E through miR-4270 278
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers 266
SARS-CoV-2 infection and replication in human gastric organoids 232
Infectivity in full-term placenta of Zika viruses with different lipid profiles 227
Helicobacter pylori affects the antigen presentation ability of macrophages modulating the expression of the immune receptor CD300E through miR-4270 224
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 209
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays 208
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults 197
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5–11 years old children with prior COVID-19 181
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 178
Host Response of Syrian Hamster to SARS-CoV-2 Infection including Differences with Humans and between Sexes 174
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays 172
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient 138
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 121
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 115
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 93
Totale 3.687
Categoria #
all - tutte 10.722
article - articoli 9.977
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 12 8 0 1 28 24 3 8 3 16 30
2022/2023137 28 18 6 21 15 23 2 6 9 1 7 1
2023/2024149 7 11 16 13 12 14 9 16 10 17 9 15
2024/2025623 6 36 37 27 66 22 37 53 39 31 121 148
2025/20262.221 151 131 269 330 241 100 222 180 231 128 116 122
2026/2027278 100 178 0 0 0 0 0 0 0 0 0 0
Totale 3.687